Abdul Hamid Muhammad Azrul Bin
CIK: 0002141872
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BGLC
BioNexus Gene Lab Corp
Director
Discretionary Trading P&L
Holdings
About Bin Abdul Hamid Muhammad Azrul
Bin Abdul Hamid Muhammad Azrul (SEC CIK 0002141872) files insider reports with the SEC as Director of BioNexus Gene Lab Corp (BGLC).
Signal8 holds 1 ownership filing by Bin Abdul Hamid Muhammad Azrul, a Form 4, filed on Aug 14, 2026. Those filings report 1 transaction, the latest on Aug 13, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bin Abdul Hamid Muhammad Azrul's filings is in BANGSAR.
Recent filings by Bin Abdul Hamid Muhammad Azrul
- Aug 13, 2026: Grant or award of BGLC shares (Form 4, code A).
Other insiders filing for BioNexus Gene Lab Corp (BGLC)
- Tan Lee Su-Leng, Chief Executive Officer
- Yap Chee Keong, Director
- Chong Set Fui, Chief Financial Officer
- Low Jook Yuen, Director
- FIDELION DIAGNOSTICS PTE. LTD., Officer